Alyeska Investment Group, L.P. Pacira Bio Sciences, Inc. Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 200,846 shares of PCRX stock, worth $5.45 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
200,846
Previous 1,308,086
84.65%
Holding current value
$5.45 Million
Previous $32.5 Million
85.23%
% of portfolio
0.02%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding PCRX
# of Institutions
257Shares Held
51.4MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$147 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$65 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$61.1 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$58.4 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.24B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...